<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03080558</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-305</org_study_id>
    <secondary_id>2016-002773-35</secondary_id>
    <nct_id>NCT03080558</nct_id>
  </id_info>
  <brief_title>Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving</brief_title>
  <acronym>INDIE</acronym>
  <official_title>Estimation of Vascularization After Treatment of Deep Rectovaginal Endometriosis Node by Rectal Shaving, Using Indocyanine Green Injection. Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratoire SERB</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association GEGO</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Indocyanine green is a dye, using in surgery to bring out the intraoperative evaluation of
      tissue perfusion.

      After intravenous injection of indocyanine green, using a near infrared light, the
      vascularisation becomes fluorescent.

      In endometriosis disease, the treatment of recto vaginal node can be complicated by
      rectovaginal fistula.

      An abnormal vascularisation related to the surgery would be a risk factor of post operative
      fistulas.

      The aim of this study is to evaluate the rectal and vaginal vascularisation during the
      treatment of a recto vaginal endometriosis nodule with rectal shaving, using indocyanine
      green fluorescence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators are going to inject, at the end of a rectal shaving, a bolus of 0,2mg/kg of
      indocyanine green after dilution (2,5mg/ml). With de SPIES system (KARL STORZ GmbH &amp; Co. KG,
      Tuttlingen, Germany), the vascularisation would be imediately fluorescent. Investigators are
      going to estimate the vascularization of the rectal serosa and mucosa where the nodule was
      located.

      If a vaginal resection has been performed, investigators are going to estimate the
      vascularization of the vaginal scar.

      To estimate de vascularization, investigators are going tu use a scale with a score between 0
      and 4.

      After the surgery, the post-operative follow-up with be the same as usual after a Rectal
      Shaving.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 6, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>open</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Per-operative evaluation of the rectum</measure>
    <time_frame>at day 1</time_frame>
    <description>Per-operative evaluation of the rectum after Shaving, using indocyanine green fluorescence, by transperitoneal and intra-rectal approach, and vaginal suture if there is an associated vaginal resection. A fluorescence score between 0 and 4 will be used, based on a Likert scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects after indocyanine green injection</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative complications</measure>
    <time_frame>at day 1</time_frame>
    <description>infections, abdominal abscess, abdominal hematoma, post operative fistula.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Deep Endometriosis</condition>
  <condition>Recto Vaginal Node</condition>
  <arm_group>
    <arm_group_label>endometriosis recto vaginal node</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine green</intervention_name>
    <description>Use of Indocyanine Green during Rectal shaving by laparoscopy.</description>
    <arm_group_label>endometriosis recto vaginal node</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients above the age of 18 year

          -  Patients with endometriosis recto vaginal node

          -  Patients with operative indications of rectal shaving, with or without vaginal
             resection

          -  Patients who have accepted to participate

        Exclusion Criteria:

          -  minors patients

          -  Patients under guardianship or wardship

          -  Patients who refused the participation

          -  Iodine allergy

          -  Pregnant woman

          -  Patients during lactation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas BOURDEL</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>0473751195</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Nicolas BOURDEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2017</study_first_submitted>
  <study_first_submitted_qc>March 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2017</study_first_posted>
  <last_update_submitted>November 30, 2017</last_update_submitted>
  <last_update_submitted_qc>November 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Indocyanine green fluorescence</keyword>
  <keyword>Rectal vascularisation</keyword>
  <keyword>Vaginal vascularisation</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <keyword>Rectal shaving</keyword>
  <keyword>Recto vaginal node</keyword>
  <keyword>Deep Endometriosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

